MRNA
Moderna, Inc (MRNA) European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release
Moderna, Inc (MRNA) Sec Form 10K
Moderna, Inc (NASDAQ: MRNA) Sec Form 10K
Moderna, Inc (MRNA) Barclays 28th Annual Global Healthcare Conference
Moderna, Inc (NASDAQ: MRNA) FY 2026 Corporate Conference
Moderna, Inc (MRNA) TD Cowen 46th Annual Healthcare Conference
Moderna, Inc (NASDAQ: MRNA) FY 2026 Corporate Conference
Moderna, Inc (MRNA) Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release
Moderna, Inc (MRNA) Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release
Moderna, Inc (MRNA) Sec Form 8K
Moderna, Inc (NASDAQ: MRNA) Sec Form 8K
Moderna, Inc (MRNA) Q4 2025 Earnings Results
Moderna, Inc (NASDAQ: MRNA) Q4 2025 Earnings Release